Stabilization of urinary THC solutions with a simple non-ionic surfactant.

J Anal Toxicol

Navy Drug Screening Laboratory, 320 B Street, Suite B, Great Lakes, Illinois 60088-2815, USA.

Published: March 2009

To stabilize urinary solutions against adsorptive loss of metabolites of Delta9-tetrahydrocannabinol (THC), a non-ionic surfactant, Tergitol, was investigated to reduce the need for special handling and storage of such solutions. Addition of surfactant up to 20 times the critical micelle concentration (CMC) did not adversely affect the analytical process. Yet, at only two times CMC, surfactant was found to mitigate adsorptive loss of THC analytes under a variety of storage and handling conditions including exposure to glass and plastic surfaces, after storage in a refrigerator or freezer, and at reduced pH, where adsorptive losses were expected to be significant. On average, micellar solubilization of analyte increased the assayed concentration by 10% with a range of 3 to 20%, depending on condition, relative to solutions without surfactant. Solutions with surfactant did not fail (i.e., deviate in concentration by +/-20%) over a 49-week period, whereas those without surfactant failed by 21 weeks. These results indicate that addition of small amounts of non-ionic surfactant to solutions of urinary THC metabolites is a simple method to improve both the accuracy and precision of analyte concentrations, as determined by gas chromatography-mass spectrometry, in such solutions by mitigating adsorptive losses during storage and handling events.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jat/33.1.51DOI Listing

Publication Analysis

Top Keywords

non-ionic surfactant
12
urinary thc
8
surfactant
8
adsorptive loss
8
storage handling
8
adsorptive losses
8
solutions surfactant
8
surfactant solutions
8
solutions
7
stabilization urinary
4

Similar Publications

Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery.

AAPS PharmSciTech

January 2025

Consulting, Fort Collins, Colorado, USA.

Continuously explored in pharmaceuticals, microemulsions and nanoemulsions offer drug delivery opportunities that are too significant to ignore, namely safe delivery of clinically relevant drug doses across biological membranes. Their effectiveness as drug vehicles in mucosal and (trans)dermal delivery is evident from the volume of published literature. Commonly, their ability to enhance skin permeation is attributed to dispersion size, a characteristic closely related to solubilization capacity.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a green and effective pesticide formulation using nanoemulsions, including adjuvants like Calcium Alkyl Benzene Sulphonate (Atlox 4838B) and trisiloxane ethoxylate (ARGAL), aimed at targeting the pest Sitophilus oryzae.
  • Results indicate that all formulations achieved nanoscale droplets, with scanning electron microscopy revealing their spherical shapes, while dynamic light scattering showed variations in size based on the presence of adjuvants.
  • The nanoemulsions demonstrated good stability under various conditions, with most formulations having acidic to neutral pH levels, and adjuvants enhanced their stability by altering droplet characteristics and increasing kinetic stability.
View Article and Find Full Text PDF

This study explores mesoporous bioactive glasses (MBGs) that show promise as advanced therapeutic delivery platforms owing to their tailorable porous properties enabling enhanced drug loading capacity and biomimetic chemistry for localized, sustained release. This work systematically investigates the complex relationship between MBG composition and surfactant templating on structural evolution, bioactive response, resultant drug loading efficiency and release. A total of 12 samples of sol-gel-derived MBG were synthesized using cationic and non-ionic structure-directing agents (cetyltrimethylammonium bromide, Pluronic F127 and P123) while modulating the SiO/CaO content, generating MBG with surface areas of 60-695 m/g.

View Article and Find Full Text PDF

: Drugs exhibiting poor aqueous solubility present a challenge to efficient delivery to the site of action. Spanlastics (a nano, surfactant-based drug delivery system) have emerged as a powerful tool to improve solubility, bioavailability, and delivery to the site of action. This study aimed to better understand factors affecting the physicochemical properties of spanlastics, quantify their effects, and use them to enhance the bioavailability of famotidine (FMT), a model histamine H2 receptor antagonist (BCS class IV).

View Article and Find Full Text PDF

Choline-acetyltransferase (ChAT) is the key cholinergic enzyme responsible for the biosynthesis of acetylcholine (ACh), a crucial signaling molecule with both canonical neurotransmitter function and auto- and paracrine signaling activity in non-neuronal cells, such as lymphocytes and astroglia. Cholinergic dysfunction is linked to both neurodegenerative and inflammatory diseases. In this study, we investigated a serendipitous observation, namely that the catalytic rate of human recombinant ChAT (rhChAT) protein greatly differed in buffered solution in the presence and absence of Triton X-100 (TX100).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!